Protalix BioThera (PLX) to Supply U.S. FDA with Additional Data Tied to Taliglucerase Alfa NDA
Tweet Send to a Friend
Protalix BioTherapeutics, Inc. (AMEX: PLX) announced today that, in connection with the New Drug Application (NDA) filed by the Company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
